InflaRx N.V. (IFRX) Financials

IFRX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 190.4 million 23.6 million
March 31, 2026 56.1 million 13.8 million
Dec. 31, 2025 64.8 million 16.0 million
Sept. 30, 2025 76.5 million 23.2 million

IFRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.0 million 674924
March 31, 2026 -8.6 million 1.1 million
Dec. 31, 2025 -5.5 million -4.2 million
Sept. 30, 2025 -10.7 million 699281

IFRX Net Income

No data available :(

IFRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 180.8 million - 639414
March 31, 2026 45.7 million - 655870
Dec. 31, 2025 54.5 million - 752157
Sept. 30, 2025 52.4 million - 1.1 million

IFRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 134.3 million
March 31, 2026 82.8 million
Dec. 31, 2025 79.0 million
Sept. 30, 2025 79.9 million

IFRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 42223 5.4 million 2.9 million 34438
March 31, 2026 11024 4.8 million 3.8 million 123846
Dec. 31, 2025 2405 6.2 million 3.5 million -1.9 million
Sept. 30, 2025 103237 7.3 million 4.4 million 1.4 million

IFRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 101549
Dec. 31, 2025 -39833 5.7 million
Sept. 30, 2025 27965 390

IFRX

Price: $1.32

52 week price:
0.80
2.95

Earnings Per Share: -0.58 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Germany

Volume: 38219

Market Capitalization: 232.7 million

Links: